Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan
Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan have?
Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan has 41 citations in the OpenAlex counts ScholarIQ stores.
When was Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan published?
Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan has 2014 year in the ScholarIQ index.
What is the open-access status of Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan?
Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan has bronze oa status in the ScholarIQ index.
What is the DOI of Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan?
The DOI for Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan is on the source record.
What is the PMID of Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan?
The PMID for Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan is on the source record.
What is the OpenAlex record for Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan?
The OpenAlex for Risk of tuberculosis, serious infection and lymphoma with disease‐modifying biologic drugs in rheumatoid arthritis patients in Taiwan is on the source record.